CClinicalTrials.gg
RecruitingNCT06719037Updated Jan 7, 2025

Comparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal Stenosis

An interventional study of Endo-Surgi Plus endoscopic surgery and Unilateral biportal endoscopic surgery in Lumbar Spinal Stenosis, sponsored by Qilu Hospital of Shandong University. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-01-07.

Sponsored by Qilu Hospital of Shandong University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2024; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
324
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to conduct a multicenter comparison of the clinical efficacy of Endo-Surgi Plus endoscopic technique, UBE endoscopic technique, and microdiscectomy technique in the treatment of lumbar spinal stenosis, and to compare the differences in the incidence of complications, surgical trauma, and other aspects among the three surgical techniques for the treatment of lumbar spinal stenosis.

Each group of patients received either Endo-Surgi Plus endoscopy, UBE, or microdiscectomy decompression through the Quadrant channel. All patients were routinely administered low-dose hormones, dehydrating agents, and neurotrophic drugs postoperatively. Patients were required to strictly avoid strenuous activities and heavy lifting in the lumbar region for three months after surgery. Upon discharge, patients were provided with the same lumbar and back muscle rehabilitation exercises and other postoperative recovery-related discharge education. Each group of patients was followed up for at least one year, with follow-up including outpatient visits, physical examinations, questionnaire scoring, and necessary auxiliary examinations.

Both two endoscopic surgeries, as surgical techniques that have been used in clinical practice for many years, have their efficacy confirmed by various studies. The investigator proposes that these two techniques may have similar clinical efficacy to microdiscectomy, while also offering the advantage of being less invasive. The aim of this study is to validate these assumptions. At the same time, there may be some differences between the two endoscopic surgeries that require further verification.

Read the detailed description

The lumbar spine is the part of the spine that bears the most weight, consisting of five vertebrae. Each vertebra is connected by an intervertebral disc, and together they form a barrier to protect the spinal cord nerves within the spinal canal. Lumbar spinal stenosis refers to the reduction of space within the lumbar spinal canal, which compresses the spinal cord or nerve roots, leading to a series of symptoms. Depending on the cause, lumbar spinal stenosis is mainly divided into congenital lumbar spinal stenosis, which is due to abnormal development of the spinal canal, and acquired lumbar spinal stenosis, which is caused by degenerative changes such as lumbar disc degeneration and joint process hyperplasia. Lumbar spinal stenosis is a common cause of low back and leg pain, with a reported incidence rate as high as 11% in the general population and 19.4% in those over 60 years old, with a trend of increasing with age. With the aging of the population, the incidence of lumbar spinal stenosis is also on the rise.

The treatment of lumbar spinal stenosis mainly includes conservative treatment and surgical treatment. For patients whose symptoms severely affect their lives and do not respond well to conservative treatment, surgery should be performed as soon as possible to relieve nerve compression. The main goal of surgical treatment for lumbar spinal stenosis is to relieve nerve compression, stabilize the spine, and restore the normal volume of the spinal canal. Although traditional posterior lumbar decompression surgery can achieve definite decompression effects, it has issues such as severe destruction of posterior column structures and large surgical trauma. Minimally invasive techniques are a hot topic in various clinical fields, and microdiscectomy (MD) through a minimally invasive channel is a mature minimally invasive technique for treating lumbar spinal stenosis. As early as 1999, prospective randomized controlled studies confirmed that it has the same excellent clinical efficacy as open surgery but with less surgical trauma. It has now become a classic surgical method for treating lumbar spinal stenosis, with related articles published in the top spinal clinical journal JBJS.

In recent years, with the development of new equipment, endoscopic techniques have been gradually applied to the treatment of lumbar spinal stenosis. Unilateral biportal endoscopic discectomy (UBE) has the characteristics of convenient operation and flexibility because its endoscopic channel and working channel are separate and can use traditional open instruments. It can achieve good decompression effects and has been widely used in various medical centers. Percutaneous endoscopic lumbar discectomy (PELD), as a new generation of endoscopic technique, has less surgical trauma and shorter operation time. It has also been successfully applied to the clinical treatment of lumbar spinal stenosis and achieved good results. However, due to the limitations of the single-endoscopic channel field of view, its learning curve is steep, the surgical difficulty is high, and it is difficult to achieve complete decompression for bilateral spinal stenosis or dorsal nerve root compression. The efficiency of dealing with bony stenosis structures during surgery is low, leading to longer operation time and increased risk of nerve root and dural sac injury. Many clinical studies have compared the advantages and disadvantages of endoscopic techniques with traditional minimally invasive techniques and different endoscopic techniques, concluding that various endoscopic techniques can achieve surgical efficacy similar to traditional techniques with the advantages of less surgical trauma and faster postoperative recovery. Guilherme et al. believe that PELD has similar clinical efficacy to MD, but MD is superior for complex foraminal stenosis. In addition, a review by Ohyuk et al. suggests that UBE has better clinical efficacy and a lower complication rate compared to MD or PELD. However, most of these studies are small-scale, single-center, and retrospective, and the conclusions lack high-quality evidence support.

In recent years, single-channel decompression techniques under endoscopy have developed rapidly, especially large-channel endoscopes and related tools, which have significantly improved work efficiency and surgical safety. Many hospitals and medical research centers have introduced the Endo-Surgi Plus working channel, which has a larger working tube than traditional endoscopes, making it easier to treat certain types of lumbar disc herniation and lumbar spinal stenosis, further optimizing spinal endoscopic surgery techniques for lumbar spinal stenosis.

With the development of surgical instruments and approaches, these three minimally invasive spinal canal decompression techniques can effectively relieve pain symptoms in patients with various types of lumbar spinal stenosis. Compared with traditional open surgery, these techniques have reduced operation time, intraoperative blood loss, and postoperative pain. However, there are slight differences in the degree of trauma and ease of operation among these three techniques. Currently, there is still a lack of prospective validation of the clinical efficacy of these surgical techniques internationally, and the advantages and disadvantages of different endoscopic surgeries compared to traditional fenestration surgery.The purpose of this study is to conduct a multicenter comparison of the clinical efficacy of Endo-Surgi Plus endoscopic technique, UBE endoscopic technique, and microdiscectomy technique in the treatment of lumbar spinal stenosis.

Subjects were randomly divided into the Endo-Surgi Plus endoscopy group, the UBE group, and the fenestration group through the Quadrant channel. Randomization (1:1:1 grouping) was conducted within 2 weeks before surgery. Investigators used a block randomization design, stratified by 23 hospitals, with non-competitive enrollment between hospitals. The blocks were kept as small as possible (randomly selected block sizes of 3 and 6) to ensure that each hospital performed a similar number of all three types of surgeries. The computer-generated allocation output was sent via email to the local study coordinators (CRC), who did not participate in patient recruitment or treatment.

Due to the nature of the interventions, double blinding was not feasible. Randomization of patients aimed to reduce potential biases in preoperative planning and patient treatment. Throughout the study, outcome assessors and data analysts remained blinded to reduce biases in clinical outcome assessment and data analysis. Patients were informed that no treatment regimen was recorded as superior to another.

Determination of Sample Size: This study is a randomized controlled trial, with the postoperative 1-year ODI score of the subjects as the main outcome indicator. The trial required 324 patients to be included in total, with 80% statistical power to detect a difference of at least 12 points in ODI scores between treatment groups at a significance level of 0.05.Investigators conservatively chose a difference of 12 points because the U.S. Food and Drug Administration suggests that a 15-point reduction in ODI score indicates a minimally important improvement after spinal fusion surgery. Investigators conservatively set the standard deviation of the ODI score to 18, and estimated a dropout rate of 15%. Finally investigators used PASS to estimate that the trial would need to include a total of 324 patients.

Statistical and Analytical Plan: Patients who underwent the designated surgery and completed at least one year of follow-up were included. For continuous data that met normal distribution, analysis of variance (ANOVA) and post-hoc tests were used to compare differences among the three treatment groups; otherwise, the Kruskal-Wallis H-test was applied. Categorical variables were analyzed using chi-square or Fisher's exact test (expressed in numbers and percentages) to compare baseline characteristics among groups.

A mixed-effects model for repeated measures was used to compare changes in ODI and SF-36 scores relative to baseline across groups. Considering the correlation of repeated measures within patients, an unstructured covariance matrix was specified. The model included fixed effects for treatment (Endo-Surgi Plus endoscopy, UBE, minimally invasive fenestration), time (2 days, 1 month, 3 months, 1 year postoperatively), and time-treatment interaction, with results reported as least squares means and 95% confidence intervals. Robust standard errors and test statistics were calculated for the fixed effects. Appropriate comparisons were made within the mixed-effects model for repeated measures to compare least squares means between treatment groups at each time point and within each treatment group across time points. Considering the various etiologies of lumbar spinal stenosis such as disc degeneration, ligamentum flavum hypertrophy, and bone hyperplasia, this study will perform multivariate adjustments and subgroup analyses based on etiology. All analyses were conducted using R software version 4.3.3, primarily utilizing the lme4 and emmeans packages. A P-value of less than 0.05 was considered statistically significant.

02

Conditions studied

  • Lumbar Spinal Stenosis

Keywords

  • Microdiscectomy
  • Endoscopic
  • Unilateral Biportal Endoscopic
  • Endo-surgi Plus endoscopy
  • ODI
  • Complication
  • CK-MB
03

In context

Spinal Stenosis

459 studies on the registry are indexed under Spinal Stenosis; 103 are open to participants now.

This study's planned enrollment of 324 is above the median of 80 across 283 interventional studies indexed under Spinal Stenosis.

Browse Spinal Stenosis studies →

Lead sponsor

Qilu Hospital of Shandong University is the lead sponsor of 299 studies on the registry; 181 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with single-segment lumbar spinal stenosis through CT and MRI imaging combined with clinical symptoms;
  • Symptoms in the lumbar region and lower extremities corresponding to the imaging findings;
  • Patients who have not responded to three months of conservative treatment;
  • Informed consent from family members regarding the surgical procedure and associated risks.

Exclusion criteria

Exclusion Criteria:

  • Patients with multi-segment lumbar disc herniation, malignant spinal tumors, spinal deformities, and other diseases.
  • Patients with comorbidities such as cardiovascular diseases, cerebrovascular diseases, or those with mental abnormalities, communication difficulties, or other issues that may affect clinical evaluation.
  • Patients with a history of previous lumbar surgery.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
324 participants (estimated)

Study arms

  • Experimental
    Endo-Surgi Plus endoscopic group

    Procedure: Endo-Surgi Plus endoscopic surgery

  • Experimental
    Unilateral biportal endoscopic group

    Procedure: Unilateral biportal endoscopic surgery

  • Active comparator
    Microdiscectomy group

    Procedure: Microdiscectomy

Interventions

  • ProcedureEndo-Surgi Plus endoscopic surgery

    Endo-Surgi Plus endoscopic surgery, as a new type of percutaneous endoscopic lumbar discectomy (PELD), features a larger working channel and represents an optimized single-channel endoscopic technique. However, it still has the limitations inherent in single-channel endoscopy.

  • ProcedureUnilateral biportal endoscopic surgery

    Unilateral biportal endoscopic discectomy (UBE) is characterized by its separate endoscopic and working channels, and the ability to use traditional open instruments, making it a convenient and versatile technique. It is a commonly used spinal endoscopic surgery in clinical practice.

  • ProcedureMicrodiscectomy

    Microdiscectomy (MD) is a mature minimally invasive technique that uses a microscope to treat lumbar spinal stenosis. As early as 1999, prospective randomized controlled studies confirmed that it has equally excellent clinical efficacy compared to open surgery, with less surgical trauma. It is currently the classic minimally invasive surgical approach for treating lumbar spinal stenosis.

06

What researchers measure

Primary outcomes

  1. The Oswestry Disability Index scores

    The maximum score is 100 points, and the minimum score is 0 points. The higher the score, the more severe the functional impairment.

    Time frame: 1 year postoperatively

Secondary outcomes

  1. The Oswestry Disability Index scores

    The maximum score is 100 points, and the minimum score is 0 points. The higher the score, the more severe the functional impairment.

    Time frame: preoperatively, 1 day, 3 months, and 6 months postoperatively

  2. Visual Analogue Score for lower limb pain/lumbar back pain

    The maximum score is 10 points, and the minimum score is 0 points. A higher score means a worse outcome and a more severe pain.

    Time frame: preoperatively, 1 day, 3 months, 6 months, and 1 year postoperatively

  3. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36 score)

    The scales was divided into 9 parts. For each part, the maximum score is 100 points, and the minimum score is 0 points. A higher score means the better outcome.

    Time frame: preoperatively, 1 day, 3 months, 6 months, and 1 year postoperatively

  4. Dural sac cross-sectional area calculated from lumbar MRI

    The Dural sac cross-sectional area (DCSA) refers to the two-dimensional area enclosed by the outer boundary of the dural sac as seen on imaging, typically measured in square millimeters (mm²). A reduced DCSA is often used to diagnose spinal stenosis. Anterior Boundary: The posterior longitudinal ligament and the vertebral body or intervertebral disc. Posterior Boundary: The inner surface of the ligamentum flavum or the posterior vertebral arch. Lateral Boundary: The inner walls of the pedicles or the edges of the vertebral foramen. These boundaries are identified on axial MRI imaging. The increase rate of the postoperative dural sac cross-sectional area at the last follow-up would be also calculated using Image J, which was defined as the \[(postoperative dural sac cross-sectional area - preoperative dural sac cross-sectional area) / preoperative dural sac cross-sectional area\].

    Time frame: preoperatively and at 1 year postoperatively

  5. Creatine kinase-MB (CK-MB)

    preoperative and immediate postoperative changes in creatine kinase-MB (CK-MB)

    Time frame: preoperative and immediate postoperative

  6. Surgery time

    Time frame: Immediate postoperatively

  7. Intraoperative blood loss

    Time frame: Immediate postoperatively

  8. Surgical incision length

    Time frame: Immediate postoperatively

  9. Postoperative hospital stay

    Time frame: Immediate postoperatively

  10. Perioperative complication rate

    Time frame: Immediate postoperatively

07

Study locations

1 of 1 sites recruiting
  • Qilu Hospital of Shandong University
    Jinan, Shandong 250012, China
    Recruiting
08

References and documents

Publications

  • Han S, Zeng X, Zhu K, Wu X, Shen Y, Han J, Lin A, Meng S, Zhang H, Li G, Liu X, Tao H, Ma X, Zhou C. Clinical Application of Large Channel Endoscopic Systems with Full Endoscopic Visualization Technique in Lumbar Central Spinal Stenosis: A Retrospective Cohort Study. Pain Ther. 2022 Dec;11(4):1309-1326. doi: 10.1007/s40122-022-00428-3. Epub 2022 Sep 3. PubMed 36057015 ↗
  • Katz JN, Zimmerman ZE, Mass H, Makhni MC. Diagnosis and Management of Lumbar Spinal Stenosis: A Review. JAMA. 2022 May 3;327(17):1688-1699. doi: 10.1001/jama.2022.5921. PubMed 35503342 ↗
  • Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F, Grimshaw JM, Kelly LE, Saeed L, Thabane L, Askie L, Smith M, Farid-Kapadia M, Williamson PR, Szatmari P, Tugwell P, Golub RM, Monga S, Vohra S, Marlin S, Ungar WJ, Offringa M. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension. JAMA. 2022 Dec 13;328(22):2252-2264. doi: 10.1001/jama.2022.21022. PubMed 36511921 ↗
  • Ghogawala Z, Dziura J, Butler WE, Dai F, Terrin N, Magge SN, Coumans JV, Harrington JF, Amin-Hanjani S, Schwartz JS, Sonntag VK, Barker FG 2nd, Benzel EC. Laminectomy plus Fusion versus Laminectomy Alone for Lumbar Spondylolisthesis. N Engl J Med. 2016 Apr 14;374(15):1424-34. doi: 10.1056/NEJMoa1508788. PubMed 27074067 ↗
  • Forsth P, Olafsson G, Carlsson T, Frost A, Borgstrom F, Fritzell P, Ohagen P, Michaelsson K, Sanden B. A Randomized, Controlled Trial of Fusion Surgery for Lumbar Spinal Stenosis. N Engl J Med. 2016 Apr 14;374(15):1413-23. doi: 10.1056/NEJMoa1513721. PubMed 27074066 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06719037
Lead sponsor
Qilu Hospital of Shandong University
Responsible party
Sponsor
First posted
Dec 5, 2024
Start date
Dec 8, 2024
Primary completion
Jun 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Jan 7, 2025

Study contacts

Xinyu Yang, M.D.
Contact
dr_xinyuyang@163.com
+8618560089496

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion